Geode Capital Management LLC Has $102.32 Million Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Geode Capital Management LLC increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 0.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,613,198 shares of the company's stock after purchasing an additional 14,197 shares during the period. Geode Capital Management LLC owned approximately 1.74% of Acadia Healthcare worth $102,320,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ACHC. Blue Trust Inc. boosted its position in shares of Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company's stock valued at $36,000 after acquiring an additional 248 shares during the period. GAMMA Investing LLC boosted its holdings in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after purchasing an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth approximately $59,000. Covestor Ltd raised its position in shares of Acadia Healthcare by 834.4% in the third quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after buying an additional 1,018 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare in the third quarter valued at approximately $86,000.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. KeyCorp began coverage on Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating on the stock. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and raised their price target for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Cantor Fitzgerald reiterated a "neutral" rating and set a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Barclays dropped their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating for the company in a research report on Friday, November 22nd. Finally, Royal Bank of Canada reduced their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating on the stock in a research report on Monday, November 18th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $75.44.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC traded down $0.46 during mid-day trading on Thursday, hitting $38.59. 1,286,624 shares of the stock traded hands, compared to its average volume of 1,048,428. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77. The firm has a 50 day simple moving average of $44.48 and a two-hundred day simple moving average of $61.24. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market cap of $3.58 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business's revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the firm posted $0.91 earnings per share. As a group, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.